BETA: Please send your feedback!
Sarepta Therapeutics
SRPT:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 1980
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. It focuses on the development of its potentially disease-modifying DMD drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
website
Headquarters
Executives
Name | Title | Gender |
Edward M. Kaye, MD | President & Director | Male |
TY Howton, Jr. | Secretary, Senior Vice President & General Counsel | Male |
M. Kathleen Behrens, PhD | Chairman | Female |
Sandesh Mahatme | Executive VP, Chief Financial & Business Officer | Male |
Ian Estepan | Head-Investor & Media Relations | Male |
Diane Berry, PhD | VP-Global Health Policy & Government Affairs | Female |
Joan Wood | Vice President & Head-Human Resources | Female |
Shamim Ruff | Senior Vice President-Regulatory Affairs & Quality | Female |
Catherine Stehman Breen, MD | Chief Medical Officer | null |
Mindful Investing Summary
Sarepta Therapeutics - Competitors and Related Companies
How Sarepta Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Sarepta Therapeutics
SRPT:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
BioCryst Pharmaceuticals
BCRX:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Novavax
NVAX:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
PTC Therapeutics
PTCT:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- 2
- 3
- 1
- 1
- —
- 3
- 4
- 1
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Retrophin
RTRX:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Hemispherx Biopharma
HEB:ASE
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership